Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
about
Progression of cutaneous melanoma: implications for treatmentExperimental procedures to identify and validate specific mRNA targets of miRNAsEmerging technologies for studying DNA methylation for the molecular diagnosis of cancerIntegration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cellsEpigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategiesDNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterationsActivation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis.DNA-methylation profiling distinguishes malignant melanomas from benign nevi.miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.MicroRNA in Melanoma.Cell-specific post-transcriptional regulation of γ-synuclein gene by micro-RNAs.Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencingEpigenetic biomarkers in skin cancer.Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC.miRNA-532-5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3.Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.The role of miR-18b in MDM2-p53 pathway signaling and melanoma progressionQuantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma.Prognostic molecular biomarkers for cutaneous malignant melanomaHigh Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro.Thrombospondin-1 is a putative target gene of Runx2 and Runx3.Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma.Metastamirs: a stepping stone towards improved cancer management.MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.Oncogenic role of RUNX3 in head and neck cancer.Control of RUNX3 by histone methyltransferases.MicroRNAs in the pathogenesis of malignant melanoma.Driving transcriptional regulators in melanoma metastasis.Epigenetics of regional lymph node metastasis in solid tumors.MicroRNAs and photocarcinogenesis.RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.MicroRNAs role as potential biomarkers and key regulators in melanoma.MicroRNA-148a can regulate runt-related transcription factor 3 gene expression via modulation of DNA methyltransferase 1 in gastric cancerExpression of RUNX3 in skin cancers.Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.Molecular mechanisms of metastasis.Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis.LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression.Differential microRNA expression in breast cancer with different onset age.
P2860
Q27001734-AF0C2E47-085F-4E75-87EC-7D13AB190ED3Q28087216-B32242D7-EA7B-4827-BCB9-35E68EC775C3Q28087759-21E1AC06-5A36-435E-AB76-FECED754D04FQ33670486-D8BD16D8-7000-4B10-9986-E2F790A10AA1Q33873336-CBC89B4D-D78A-4A45-9BAC-C034F72E2635Q33980682-230FAF0D-81D5-4AFA-8D23-93BE118D986DQ34359695-0ACB1E74-D7C8-4377-9E8C-9CD96D7134D6Q34731651-8AC7187A-414B-4409-83BF-4D857FC4F161Q34775571-237F27A8-E208-4132-9F91-281C06CD7770Q34947386-E15EFAE4-D0AC-4172-9E4F-8E721E554401Q34986222-42D4E7C9-F1F2-4DF6-95E5-1629C7AD909CQ34989307-4D8CE0FB-96D0-42D1-9491-C6526665790EQ35153783-D43EF80B-9E27-47AA-8D1C-FF76A0921050Q36080974-7E937C48-FC30-421F-B56F-C0C09850C684Q36420234-BACE700C-B851-4EE4-9EF5-DC64022E5F3FQ36476894-3DEAB4AE-5C5E-4707-8D17-C7A328E6FEA4Q36545132-7067BFF1-F1CB-41A2-A6CD-9852D80C3BCCQ36697766-01AD7B1E-3EA1-46A7-A79A-BFD56B84F6E5Q36745120-6C91055E-A29B-4AC8-91B3-2314BD301DD9Q36905877-8FD85F75-BA89-4AEA-B6F5-E9E465E26887Q36917944-53E4E1D4-4004-48A8-A020-0C5F5B1EE358Q37091945-713C211D-85D0-4041-A69E-C7471FEFE37AQ37478182-F318A5A8-6C2F-4298-B9EF-9D63E82B6B79Q37806613-28B13EE7-32A9-4FE6-B2C2-23EA5467E1D2Q37828424-84CB54CC-328B-405F-988A-406779E79CE2Q37832454-86E87382-FD74-4A31-A359-D8280FCE81B1Q37832455-11B43FB9-537F-4389-A3BF-C6DA84AA8E98Q38012532-1B307ECC-9B98-4419-8641-620F14FF0151Q38017594-B9851378-AFD3-414F-9AA3-538960DA9258Q38017604-48904BB4-2B53-4260-9CBF-0E94477714A9Q38250171-F94DB0D7-F964-478E-80C2-2854BE9FC7B9Q38730513-30272784-8D77-49C5-AEA1-3431691A8D82Q38937088-D7AAF0A3-76A4-4AB7-840E-07B8F4558123Q39172335-982B3D6E-D3DF-47FF-943D-5AF5FC68A74DQ39533871-BE3F1E16-3875-4F5D-A903-27793F721BE7Q39756781-3A9487D5-4295-436A-BC44-EA1E64581124Q46055814-AFFA9997-3F69-44F5-9B6C-9FE838617B81Q46250385-01066CE3-3D75-4E80-80AF-56BB1C6F6272Q47193400-E1AC9A91-2E5C-4AD0-B354-AA295766FA71Q48259419-D4B0FA34-E9F2-4914-AC6F-E79B33313CE4
P2860
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@en
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@nl
type
label
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@en
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@nl
prefLabel
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@en
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@nl
P2093
P2860
P1476
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
@en
P2093
Dave S B Hoon
Minoru Kitago
Myung-Shin Sim
Steve R Martinez
Takeshi Nakamura
P2860
P304
P356
10.1158/1078-0432.CCR-08-3172
P407
P577
2009-03-31T00:00:00Z